A rat model of Parkinson's disease induced by Japanese encephalitis virus

References

• Adams J D, Odunze I N. Oxigen free radicals and Parkinson's disease. Free Radical Biol Med 1991; 10: 161–169
   PubMed Web of Science ®Google Scholar
• Alves R S C, Barbosa E R, Scaff M. Postvaccinial parkinsonism. Movement Disorders 1992; 7: 178–180
   PubMed Web of Science ®Google Scholar
• Appel S H, Le W ‐D, Tajti J, Haverkamp L J, Engelhardt J I. Nigral damage and dopaminergic hypofunction in mesencephalon‐immunized guinea pigs. Ann Neurol 1992; 32: 494–501
   Google Scholar
• Ballard P A, Tetrud J W, Langston J W. Permanent human parkinsonism due to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): seven cases. Neurology 1985; 35: 949–956
   PubMed Web of Science ®Google Scholar
• Bojinov S. Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci 1971; 12: 383–415
   PubMed Web of Science ®Google Scholar
• Burns R S, Chiueh C C, Markey S P, Ebert M H, Jacobowitz D M, Kopin I J. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Proc Natl Acad Sci USA 1983; 80: 4546–4550
   PubMed Web of Science ®Google Scholar
• Calne D B, Langston J W. Aetiology of Parkinson's disease. Lancet 1983; ii: 1457–1459
   Google Scholar
• Chiueh C C, Markey S P, Burns R S, et al. N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine, a parkinsonian syndrome causing agent in man and monkey, produces different effects in guinea pig and rat. Pharmacologist 1983; 25: 131
   Google Scholar
• Cohen G. Monoamine oxidase, hydrogen peroxidase and Parkinson's disease. Adv Neurol 1986; 45: 119–125
   Google Scholar
• Dexter D T, Wells F R, Lees A J, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989; 52: 1830–1836
   PubMed Web of Science ®Google Scholar
• Dickerson R B, Newton J R, Hansen J E. Diagnosis and immediate prognosis of Japanese B encephalitis. Am J Med 1952; 12: 277–288
   PubMedGoogle Scholar
• Duvoisin R C, Yahr M D. Encephalitis and parkinsonism. Arch Neurol 1965; 12: 227–239
   PubMed Web of Science ®Google Scholar
• Fishman P S, Gass J S, Swoveland P T, Lavi E, Highkin M K, Weiss S R. Infection of the basal ganglia by a murine coronavirus. Science 1985; 229: 877–879
   Google Scholar
• Geddes J F, Hughes A J, Lees A J, Daniel S E. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism‐dementia complex. Brain 1993; 116: 281–302
   PubMedGoogle Scholar
• Gibb W R G, Lees A J. The progression of idiopathic Parkinson's disease is not explained by age‐related changes. Clinical and pathological comparisons with post‐encephalitic parkinsonian syndrome. Acta Neuropathol (Bed) 1987; 73: 195–201
   PubMedGoogle Scholar
• Goto A. Follow‐up study of Japanese B encephalitis. Psychiat Neurol Jpn (Tokyo) 1962; 64: 236–266
   Google Scholar
• Heikkila R E, Hess A, Duvoisin R C. Dopaminergic neurotoxicity of 1‐methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine in mice. Science 1984; 224: 1451–1453
   PubMed Web of Science ®Google Scholar
• Hsu S M, Raine L, Fanger H. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Hudson A J, Rice G P A. Similarities of Guamanian ALS/PD to post‐encephalitic parkinsonism/ALS: possible viral cause. Can ‘Neurol Sci 1990; 17: 427–433
   Google Scholar
• Kelly P H, Seviour P W, Iversen S D. Amphetamine and apomorphine responses in the rat following 6‐OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Research 1975; 94: 507–522
   PubMed Web of Science ®Google Scholar
• Kimura‐Kuroda J, Ichikawa M, Ogata A, Nagashima K, Yasui K. Specific tropism of Japanese encephalitis virus for developing neurons in primary rat brain culture. Arch Virol 1993; 130: 477–484
   PubMed Web of Science ®Google Scholar
• Kristensson K. Potential role of viruses in neuro‐degeneration. Molecular and Chemical Neuropathology 1992; 16: 45–58
   Google Scholar
• Langston J W, Ballard P, Tetrud J W, Irwin I. Chronic parkinsonism in humans due to a product of meperidine‐analog synthesis. Science 1983; 219: 979–980
   PubMed Web of Science ®Google Scholar
• Langston J W. Current theories on the cause of Parkinson's disease. J Neu Neurosurg Psychiatry 1989; 52: 13–17
   Google Scholar
• McGeer P L, Itagaki S, Akiyama H, McGeer E G. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988; 24: 574–576
   PubMed Web of Science ®Google Scholar
• Morita K, Tanaka M, Igarashi A. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol 1991; 29: 2107–2110
   PubMed Web of Science ®Google Scholar
• Nagatsu T, Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primate with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 1988; 87: 178–182
   PubMed Web of Science ®Google Scholar
• Ogata A, Nagashima K, Hall W W, Ichikawa M, Kimura‐Kuroda J, Yasui K. Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 1991; 65: 880–886
   Google Scholar
• Ogawa N, Hirose Y, Ohara T, et al. A simple quantitative bradykinesia test in MPTP‐treated mice. Res Commun Chem Pathol Pharmacol 1985; 50: 435–441
   PubMedGoogle Scholar
• Richter R W, Shimojyo S. Neurologic sequelae of Japanese B encephalitis. Neurology 1961; 11: 553–559
   Google Scholar
• Riederer P, Sotic E, Rausch W D, et al. Transition metals ferritin, glutathione and ascorbic acid in Parkinsonian brain. J Neurochem 1989; 52: 515–520
   PubMed Web of Science ®Google Scholar
• Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F. Japanese encephalitis and parkinsonism. J Neurol 1993; 240: 59–60
   Google Scholar
• Sumiyoshi H, Mori C, Fuke I, et al. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 1987; 161: 497–510
   PubMed Web of Science ®Google Scholar
• Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H. The substania nigra is a major target for neurovirulent influenza A virus. J Exp Med 1995; 181: 2161–2169
   PubMed Web of Science ®Google Scholar
• Vingerhoets F J G, Snow B J, Tetrud J W, Langston J W, Schulzer M, Calne D B. Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions. Ann Neurol 1994; 36: 765–770
   PubMed Web of Science ®Google Scholar
• von Economo C. Encephalitis lethargica. Wien klin Wschr 1917; 30: 581–585
   Google Scholar
• Walters J H. Post‐encephalitic parkinson syndrome after meningoencephalitis due to coxsackie virus group B, type 2. New Eng J Med 1960; 263: 744–747
   Google Scholar
• Yahr M D. Encephalitis lethargica (Von Economo's disease, epidemic encephalitis). Handbook of clinical neurology, P J Vinken, G W Bruyn. North‐Holland, Amsterdam 1978; volume 34: 451–457
   Google Scholar
• Yoshida M, Miwa T, Nagatsu T. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes. Neurosci Lett 1990; 119: 109–113
   Google Scholar